Moreover, the serum level of EMMPRIN was highly expressed in NSCLC patients of stages IIIB-IV (109.49±14.83 pg/mL) compared with those of stages IIA-IIIA (93.92±10.45 pg/mL) (p < 0.001). Here, BSG is linked to non-small cell lung carcinoma.